Literature DB >> 10208271

Neuroaxonal pathology in Creutzfeldt-Jakob disease.

P P Liberski1, H Budka.   

Abstract

Neuroaxonal pathology has met little attention in transmissible spongiform encephalopathies. In brains of a series of 39 consecutive Creutzfeldt-Jakob disease (CJD) cases, we detected numerous abnormal neurites that labeled for neurofilament proteins (NFP) by immunocytochemistry. Three types of abnormally NFP-accumulating structures were more prominently observed in CJD brains than in age-matched control brains: 1. Neurons with NFP in their somata were seen in 29 CJD cases (74%), some appearing distended with eccentrically placed nuclei and homogenously stained cytoplasm. 2. Neuritic distensions (neuritic swellings, dystrophic neurites) were observed mainly in the white matter but also at the junction between gray and white matter. In some axons many such swellings could be traced along the visible part of the axonal segment. 3. Axonal spheroids were observed mainly in the medulla, predominantly but not exclusively in posterior nuclei, and were more numerous than in age-matched control brains. Several neurons, axons and spheroids demonstrated immunoreactivity for amyloid precursor protein. Their number was much smaller, however, than that of NFP-immunoreactive structures and varied from one or two immunopositive neurites per section to small clusters of beaded or spiral axons. Focal expression of apolipoprotein E in cells of microglial and astrocytic morphology was observed in areas with most pronounced axonal damage. We conclude that neuroaxonal pathology is a frequent and important part of brain lesioning in CJD, probably reflecting profound impairment of axonal transport.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10208271     DOI: 10.1007/s004010050995

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  15 in total

1.  Neuritic regeneration and synaptic reconstruction induced by withanolide A.

Authors:  Tomoharu Kuboyama; Chihiro Tohda; Katsuko Komatsu
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

2.  Ablation of cytoskeletal scaffolding proteins, Band 4.1B and Whirlin, leads to cerebellar purkinje axon pathology and motor dysfunction.

Authors:  Julia Saifetiarova; Manzoor A Bhat
Journal:  J Neurosci Res       Date:  2018-11-17       Impact factor: 4.164

3.  Insights into the Impact of a Membrane-Anchoring Moiety on the Biological Activities of Bivalent Compounds As Potential Neuroprotectants for Alzheimer's Disease.

Authors:  Liu He; Yuqi Jiang; Kai Liu; Victoria Gomez-Murcia; Xiaopin Ma; Alejandro Torrecillas; Qun Chen; Xiongwei Zhu; Edward Lesnefsky; Juan C Gomez-Fernandez; Bin Xu; Shijun Zhang
Journal:  J Med Chem       Date:  2018-01-05       Impact factor: 7.446

Review 4.  Kinesin molecular motors: transport pathways, receptors, and human disease.

Authors:  L S Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

5.  Promotion of axonal maturation and prevention of memory loss in mice by extracts of Astragalus mongholicus.

Authors:  C Tohda; T Tamura; S Matsuyama; K Komatsu
Journal:  Br J Pharmacol       Date:  2006-09-18       Impact factor: 8.739

6.  Differential roles of Aβ processing in hypoxia-induced axonal damage.

Authors:  Melissa G Christianson; Donald C Lo
Journal:  Neurobiol Dis       Date:  2015-03-11       Impact factor: 5.996

7.  Reaction time impairments in decision-making networks as a diagnostic marker for traumatic brain injuries and neurological diseases.

Authors:  Pedro D Maia; J Nathan Kutz
Journal:  J Comput Neurosci       Date:  2017-04-10       Impact factor: 1.621

8.  Compromised axonal functionality after neurodegeneration, concussion and/or traumatic brain injury.

Authors:  Pedro D Maia; J Nathan Kutz
Journal:  J Comput Neurosci       Date:  2014-06-12       Impact factor: 1.621

9.  Cryo-immunogold electron microscopy for prions: toward identification of a conversion site.

Authors:  Susan F Godsave; Holger Wille; Pekka Kujala; Diane Latawiec; Stephen J DeArmond; Ana Serban; Stanley B Prusiner; Peter J Peters
Journal:  J Neurosci       Date:  2008-11-19       Impact factor: 6.167

10.  Cerebral white matter disruption in Creutzfeldt-Jakob disease.

Authors:  H Lee; O S Cohen; H Rosenmann; C Hoffmann; P B Kingsley; A D Korczyn; J Chapman; I Prohovnik
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-10       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.